Literature DB >> 33301415

Attitudes Toward Using COVID-19 mHealth Tools Among Adults With Chronic Health Conditions: Secondary Data Analysis of the COVID-19 Impact Survey.

Marlene Camacho-Rivera1, Jessica Yasmine Islam2, Argelis Rivera3, Denise Christina Vidot4.   

Abstract

BACKGROUND: Adults with chronic conditions are disproportionately burdened by COVID-19 morbidity and mortality. Although COVID-19 mobile health (mHealth) apps have emerged, research on attitudes toward using COVID-19 mHealth tools among those with chronic conditions is scarce.
OBJECTIVE: This study aimed to examine attitudes toward COVID-19, identify determinants of COVID-19 mHealth tool use across demographic and health-related characteristics, and evaluate associations between chronic health conditions and attitudes toward using COVID-19 mHealth tools (eg, mHealth or web-based methods for tracking COVID-19 exposures, symptoms, and recommendations).
METHODS: We used nationally representative data from the COVID-19 Impact Survey collected from April to June 2020 (n=10,760). Primary exposure was a history of chronic conditions, which were defined as self-reported diagnoses of cardiometabolic, respiratory, immune-related, and mental health conditions and overweight/obesity. Primary outcomes were attitudes toward COVID-19 mHealth tools, including the likelihood of using (1) a mobile phone app to track COVID-19 symptoms and receive recommendations; (2) a website to track COVID-19 symptoms, track location, and receive recommendations; and (3) an app using location data to track potential COVID-19 exposure. Outcome response options for COVID-19 mHealth tool use were extremely/very likely, moderately likely, or not too likely/not likely at all. Multinomial logistic regression was used to compare the likelihood of COVID-19 mHealth tool use between people with different chronic health conditions, with not too likely/not likely at all responses used as the reference category for each outcome. We evaluated the determinants of each COVID-19 mHealth intervention using Poisson regression.
RESULTS: Of the 10,760 respondents, 21.8% of respondents were extremely/very likely to use a mobile phone app or a website to track their COVID-19 symptoms and receive recommendations. Additionally, 24.1% of respondents were extremely/very likely to use a mobile phone app to track their location and receive push notifications about whether they have been exposed to COVID-19. After adjusting for age, race/ethnicity, sex, socioeconomic status, and residence, adults with mental health conditions were the most likely to report being extremely/very or moderately likely to use each mHealth intervention compared to those without such conditions. Adults with respiratory-related chronic diseases were extremely/very (conditional odds ratio 1.16, 95% CI 1.00-1.35) and moderately likely (conditional odds ratio 1.23, 95% CI 1.04-1.45) to use a mobile phone app to track their location and receive push notifications about whether they have been exposed to COVID-19.
CONCLUSIONS: Our study demonstrates that attitudes toward using COVID-19 mHealth tools vary widely across modalities (eg, web-based method vs app) and chronic health conditions. These findings may inform the adoption of long-term engagement with COVID-19 apps, which is crucial for determining their potential in reducing disparities in COVID-19 morbidity and mortality among individuals with chronic health conditions. ©Marlene Camacho-Rivera, Jessica Yasmine Islam, Argelis Rivera, Denise Christina Vidot. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 17.12.2020.

Entities:  

Keywords:  COVID-19; attitude; chronic disease; chronic health conditions; contact tracing; data analysis; disparity; health disparities; mHealth; mobile app; perception; smartphone

Year:  2020        PMID: 33301415     DOI: 10.2196/24693

Source DB:  PubMed          Journal:  JMIR Mhealth Uhealth        ISSN: 2291-5222            Impact factor:   4.773


  6 in total

1.  Utilization of Random Forest and Deep Learning Neural Network for Predicting Factors Affecting Perceived Usability of a COVID-19 Contact Tracing Mobile Application in Thailand "ThaiChana".

Authors:  Ardvin Kester S Ong; Thanatorn Chuenyindee; Yogi Tri Prasetyo; Reny Nadlifatin; Satria Fadil Persada; Ma Janice J Gumasing; Josephine D German; Kirstien Paola E Robas; Michael N Young; Thaninrat Sittiwatethanasiri
Journal:  Int J Environ Res Public Health       Date:  2022-05-17       Impact factor: 4.614

2.  Factors Affecting the Perceived Usability of the COVID-19 Contact-Tracing Application "Thai Chana" during the Early COVID-19 Omicron Period.

Authors:  Thanatorn Chuenyindee; Ardvin Kester S Ong; Yogi Tri Prasetyo; Satria Fadil Persada; Reny Nadlifatin; Thaninrat Sittiwatethanasiri
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

3.  Demand for Mobile Health in Developing Countries During COVID-19: Vietnamese's Perspectives from Different Age Groups and Health Conditions.

Authors:  Hung Long Nguyen; Khoa Tran; Phuong Le Nam Doan; Tuyet Nguyen
Journal:  Patient Prefer Adherence       Date:  2022-02-02       Impact factor: 2.711

4.  Characteristics and determinants of population acceptance of COVID-19 digital contact tracing: a systematic review.

Authors:  Leonardo Pegollo; Elena Maggioni; Maddalena Gaeta; Anna Odone
Journal:  Acta Biomed       Date:  2021-12-10

5.  Perceptions and Patterns of Cigarette and E-Cigarette Use among Hispanics: A Heterogeneity Analysis of the 2017-2019 Health Information National Trends Survey.

Authors:  Stephanie Cardona; Rose Calixte; Argelis Rivera; Jessica Yasmine Islam; Denise Christina Vidot; Marlene Camacho-Rivera
Journal:  Int J Environ Res Public Health       Date:  2021-06-12       Impact factor: 3.390

6.  Strengthening the Trialability for the Intention to Use of mHealth Apps Amidst Pandemic: A Cross-Sectional Study.

Authors:  Munshi Muhammad Abdul Kader Jilani; Md Moniruzzaman; Mouri Dey; Edris Alam; Md Aftab Uddin
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.